This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Howard Chang will take over as chief scientific officer and senior VP of research as the biotech searches for more ways to overcome the looming loss of exclusivity for some of its top-selling medicines.
This intersection is where pharmacognosy meets drug patents, creating a unique landscape that shapes the future of medicine. Let’s embark on a journey to uncover the secrets of nature’s medicine cabinet and the legal frameworks that protect these discoveries. ” – Dr. .
Scientists at the Northwestern University in Illinois, US, have discovered a non-invasive approach to isolate a tumour’s attack cells from blood, rather than from tumours. Scientists removed and processed melanoma tumours, and found tumour-infiltrating lymphocytes (TILs) within them.
Sandrock championed the controversial Alzheimer's drug, and was integral to the development of several other of Biogen's most important medicines during his 24 years at the biotech.
But scientists have struggled to find effective treatments for many of these diseases since the dawn of modern medicine. It is certainly a pivotal moment for the cell and gene industry, with the next decade of R&D and clinical trials expected to transform the future of medicine.
Severino left the pharma company in April after eight years as its chief scientist and then president. He'll lead Tessera Therapeutics, a well-funded genetic medicine startup.
A Swedish scientist won the 2022 Nobel Prize in medicine or physiology on Monday for his groundbreaking research into the evolutionary history of humankind. Pääbo unlocked scientists’ understanding of how genes from these extinct relatives have been passed down to present-day humans. Read the rest…
Scientists from the Lee Kong Chian School of Medicine (LKCMedicine) at Nanyang Technological University, Singapore (NTU Singapore) have found that Asians with an excess amount of visceral fat tend to have a poorer ability to think, learn, and remember.
If you enjoy working with biological samples and are enthusiastic about healthcare, a career as a clinical scientist might be just right for you. To start applying to clinical scientist jobs today, head over to the Xtalks Job Search platform. Who is a Clinical Scientist? What is it Like to Work as a Clinical Scientist?
Scientists at Kyoto University’s Institute for Cell-Material Sciences have discovered a novel cluster compound that could prove useful as a catalyst. They are found everywhere, from anti-viral medicines to rechargeable batteries and flash memory devices. Credit: Mindy Takamiya/Kyoto University iCeMS Scientists at Kyoto […].
” Therefore human beings have known the medicinal properties of cannabis since Emperor Marcus Aurelius was jotting down pithy advice for stoics between battles on the Rhine. This new technology allows scientists to make up for lost time in finding out what cannabis and other plant-based therapies can do for human health and wellness.
The future of personalised medicine In May 2023, scientists unveiled the pangenome, an update on the human reference genome that includes genetic maps of 47 people from the Americas, Europe, Africa, and Asia. For example, Sub-Saharan Africa is home to ‘The Cradle of Humankind’—the birthplace of humanity.
Medical laboratory scientists, often referred to as medical technologists or clinical laboratory scientists, analyze a variety of biological specimens. Using sophisticated equipment like microscopes, medical laboratory scientists examine and analyze blood, body fluids, tissues and cells. Medical Laboratory Scientist.
BEIJING — Hong Kong on Tuesday revoked a visa it granted to a Chinese scientist who set off an ethical debate five years ago with claims that he made the world’s first genetically edited babies, pulling it hours after he announced his research plans in the financial hub. Read the rest…
Moderna CEO Stéphane Bancel said: “Since our inception, we have always strived to be at the forefront of cutting-edge technology, leveraging innovations to deliver the greatest possible impact to people through mRNA medicines. “We Moderna aims to leverage MoLFormer to optimise lipid nanoparticles and mRNA.
Here he gives us a deeper look at how genomic medicine is evolving and the barriers that are preventing it from reaching its full potential. At that time, we thought this would be the holy grail for medicine. Now, however, the field is changing with respect to genomic medicine.
A panel of experts will debate the merits of Amylyx Pharmaceuticals' experimental medicine Wednesday. New documents from the FDA show agency scientists hold significant reservations.
Scientists now use cutting-edge techniques, including biological therapies that target specific immune system components and precision medicine approaches that personalize treatment plans based on a patient’s genetic profile.
Plasma medicine is a critical and specialized field within healthcare, centering on the use of human plasma for the development and administration of life-saving treatments. When people think about innovation drivers in global healthcare, they often think of “big pharma,” and not necessarily companies in the plasma medicines space.
Scientists now use cutting-edge techniques, including biological therapies that target specific immune system components and precision medicine approaches that personalize treatment plans based on a patient’s genetic profile.
Eisai has entered a comprehensive research partnership agreement with Washington University School of Medicine in St Louis, US, to develop potential new therapies for neurodegenerative ailments. Under the deal, the parties intend to develop treatments for diseases including Alzheimer’s and Parkinson’s.
Stanford Medicine researchers have done something similar with cancer—altering cancer cells so that they teach the body's immune system to fight the very cancer the cells came from. Some cities fight gangs with ex-members who educate kids and starve gangs of new recruits.
LA JOLLA, CA—Last year, scientists at Scripps Research and Toscana Life Sciences studied the blood of 14 COVID-19 survivors to find the most potent antibodies against the SARS-CoV-2 virus.
Wake Forest Institute for Regenerative Medicine (WFIRM) scientists have created a promising injectable cell therapy to treat osteoarthritis that both reduces inflammation and also regenerates articular cartilage.
The Eureka Institute, a Syracuse, Italy-based non-profit, is focused on addressing this disparity by providing education, research, and advocacy around the field of translational medicine. Translational medicine and digital health. The group will be leading a workshop on the topic at Frontiers Health next week. Here’s an example.
The scientists […]. Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences and the University of Chinese Academy of Sciences (UCAS) have developed a new platelet-based formulation which demonstrated potent therapeutic effects against cancer in murine models.
Scientists have spent considerable time and energy advancing these revolutionary therapies over the past few decades. With cell and gene therapy, not only does it offer the management of symptoms like other conventional medicines, but it also offers the potential of a cure. Credit: Phil Wilkinson via RoslinCT.
An experimental mRNA-based vaccine against all 20 known subtypes of influenza virus has provided broad protection from otherwise lethal flu strains in initial tests, and thus might serve one day as a general preventative measure against future flu pandemics, according to researchers from the Perelman School of Medicine at the University of Pennsylvania. (..)
Scientists at St. The findings provide a blueprint for precision medicine to further individualize therapy. The study was published today in Nature Medicine.
The Psychae Institute, established by a global team of scientists, will conduct pre-clinical and clinical research around psychedelic medicine development.
Gilead Sciences chairman and CEO Daniel O’Day said: “After more than three decades of driving advancements in HIV treatment and prevention, Gilead scientists have now delivered an innovative new option for long-acting care. Lenacapavir is a unique and potent medicine with the potential for flexible dosing options.
Our “in basket” is always open… The chief scientist at the World Health Organization says she is leaving the agency, the first of a series of high-profile departures expected at the global health body as it prepares for a post-pandemic future , Reuters writes. So please dig in.
They report their findings in npj Genomic Medicine. Researchers at the National Institutes of Health have discovered a new neurological condition characterized by issues with motor coordination and speech.
Scientists at University of Florida (UF) Scripps Biomedical Research have developed a potential medicine for a leading cause of ALS and dementia that works by eliminating disease-causing segments of RNA. The compound restored the health of neurons in the lab and rescued mice with the disease.
Snyder is a professor of medicine and the director of the Program for Building Lifestyle, Outcomes, and Care Services Research in Cancer (BLOCS) at Johns Hopkins University. Crossnohere is an assistant professor of medicine and Schuster is a research scientist at Ohio State University. Join the online meeting.
Situated in Basel, Switzerland, the newly launched Institute of Human Biology (IHB) will accommodate scientists and bioengineers from academia and the pharmaceutical sector. The knowledge that is gained will boost Roche’s drug discovery and development projects and enable medicines to reach patients faster.
Today, machine learning, artificial intelligence, and algorithmic advancements made by research scientists and engineers are driving more targeted medical therapies through the power of prediction.
Pencina is a professor of biostatistics and bioinformatics and the vice dean for data science in the Duke University School of Medicine. He is the director of the university’s Duke AI Health initiative and the chief data scientist for Duke Health. Join the online meeting.
Technological advancements have fostered novel drugs and improved precision medicine, suggesting an increased trend of R&D in this direction. Compared with a skilled scientist capable of processing 60 samples per day, full automation delivers accurate data from up to 480 samples daily.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content